Advanced Therapeutic Applications of Camel Milk in Gastrointestinal Pathology: Microbiome Modulation, Mucosal Regeneration, and the Critical Role of Processing Technologies

Abstract: This report synthesizes multi-omic data from 2024–2026 investigations regarding the efficacy of camel milk in treating Ulcerative Colitis (UC) and Irritable Bowel Syndrome (IBS). It highlights the epigenetic role of exosomal miR-148a-3p in suppressing NF-κB signaling and the mandatory requirement for Low-Temperature Spray Drying (LTSD) to preserve bioactivity.